The authors discuss the evolution of the purification platform for manufacturing of mAb therapeutics.
Ranga Godavarti
Advertisement
Articles by Ranga Godavarti
Newer classes of biotherapies will require innovations in processing technology.
Advertisement
Latest Updated Articles
Evolution of the Monoclonal Antibody Purification PlatformPublished: November 1st 2013 | Updated:
Addressing the Challenges in Downstream Processing Today and TomorrowPublished: April 2nd 2011 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
